Journal
PROSTATE
Volume 67, Issue 13, Pages 1447-1455Publisher
WILEY
DOI: 10.1002/pros.20632
Keywords
fFPE; aCGH; oCGH; biopsy
Categories
Funding
- NCI NIH HHS [P50CA89520, P50 CA089520, P50 CA089520-05] Funding Source: Medline
Ask authors/readers for more resources
BACKGROUND. The current focus on biomarker discovery is a result of an improved understanding of the biological basis for carcinogenesis and advances in technology. Biomarkers can aid in diagnosis, prognosis, treatment selection, and drug development. There is an urgent need for high-resolution tools that perform well using archived tissue for biomarker discovery and tools that can translate into the clinic. METHODS. Oligonucleotide array comparative genomic hybridization (oCGH) was compared to BAC-based aCGH using unamplified total genomic DNA from formalin fixed paraffin-embedded (FFPE) prostate tissue. RESULTS. The copy number aberrations detected with the BAC and oligonucleotide arrays were highly correlated in cases where the arrays contained probes in similar genomic locations. The oligonucleotide array platform provided more precise mapping due to the higher density of oligonucleotide probes. CONCLUSIONS. These results demonstrate the utility of high-resolution oligonucleotide arrays designed to use genomic DNA for CGH measurements using archived tissue samples for discovery and clinic based assays.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available